Eikon Therapeutics, Inc. (EIKN)

NASDAQ: EIKN · Real-Time Price · USD

5.98

-0.06 (-0.99%)

Nov 13, 2026, 4:00 PM EST - Market closed

Eikon Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	98.48	104.9	129.18	112.78
Short-Term Investments	363.24	231.07	90.93	317.63
Cash & Short-Term Investments	461.72	335.98	220.11	430.41
Cash Growth	22.84%	52.64%	-48.86%	-
Prepaid Expenses	16.01	12.54	7.38	6.01
Restricted Cash	0.4	0.4	0.4	-
Total Current Assets	478.13	348.92	227.89	436.43
Property, Plant & Equipment	219.73	233.86	259.13	86.88
Long-Term Deferred Charges	-	3.6	-	-
Other Long-Term Assets	8.35	8.35	4.22	2.4
Total Assets	706.2	594.73	491.24	525.71

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Accounts Payable	6.12	0.68	17.58	2.19
Accrued Expenses	51.24	44.16	29.16	21
Current Portion of Leases	8.91	10.03	9.31	5.05
Other Current Liabilities	-	0.14	0.4	3.21
Total Current Liabilities	66.27	55.01	56.45	31.44
Long-Term Leases	240.64	247.29	193.15	26.69
Other Long-Term Liabilities	15	10	5.35	0.73
Total Liabilities	321.91	312.3	254.95	58.86

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Common Stock	0.01	-	-	0
Additional Paid-In Capital	1,562	41.48	33.01	19.75
Retained Earnings	-1,178	-920.51	-604.94	-361.13
Total Common Equity	384.29	-879.03	-571.93	-341.37
Shareholders' Equity	384.29	282.44	236.29	466.85
Total Liabilities & Equity	706.2	594.73	491.24	525.71

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Total Debt	249.55	257.32	202.46	31.74
Net Cash (Debt)	212.17	78.66	17.65	398.68
Net Cash Growth	57.02%	345.59%	-95.57%	-
Net Cash Per Share	5.84	27.18	7.01	196.75
Filing Date Shares Outstanding	54.19	54.14	2.87	2.03
Total Common Shares Outstanding	54.18	3.07	2.87	2.03
Working Capital	411.85	293.91	171.44	404.99
Book Value Per Share	7.09	-286.47	-199.28	-168.47
Tangible Book Value	384.29	-879.03	-571.93	-341.37
Tangible Book Value Per Share	7.09	-286.47	-199.28	-168.47
Machinery	59.44	58.97	54.36	49.47
Construction In Progress	0.89	0.62	96.86	5.42
Leasehold Improvements	120.59	120.59	18.61	18.34

SEC Filings: 10-K · 10-Q